An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant PatientsTRANSPLANTATIONIF52015-10-0154OAAI
Risk Factors of Pneumocystis Pneumonia in Solid Organ Recipients in the Era of the Common Use of Posttransplantation ProphylaxisAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22015-02-01113PREAI
Prevalence, Incidence and Risk Factors for Donor-Specific Anti-HLA Antibodies in Maintenance Liver Transplant PatientsAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22014-04-0186OA
Impact of molecular adsorbent recirculating system on renal recovery in type-1 hepatorenal syndrome patients with chronic liver failureJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGYIF3.42013-05-2216PREAI
Donor-Specific Antibodies after Ceasing Immunosuppressive Therapy, with or without an Allograft NephrectomyCLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGYIF7.12012-08-0174OAAI
Anti-Human Leukocyte Antigen Immunization After Early Allograft NephrectomyTRANSPLANTATIONIF52012-05-1536OA
Hepatitis E Virus and the Kidney in Solid-Organ Transplant Patients实体器官移植患者的戊型肝炎病毒和肾脏TRANSPLANTATIONIF52012-03-27167OAAI
Biological agents in kidney transplantation: belatacept is entering the fieldEXPERT OPINION ON BIOLOGICAL THERAPYIF42010-08-2017PREAI
Pegylated Interferon-α for Treating Chronic Hepatitis E Virus Infection after Liver TransplantationCLINICAL INFECTIOUS DISEASESIF7.32010-03-01170OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向